TY  - JOUR
AU  - Papandreou, Christopher
AU  - Bullo, Monica
AU  - Tinahones, Francisco J
AU  - Martinez-Gonzalez, Miguel Angel
AU  - Corella, Dolores
AU  - Fragkiadakis, Georgios A
AU  - Lopez-Miranda, Jose
AU  - Estruch, Ramon
AU  - Fito, Montserrat
AU  - Salas-Salvado, Jordi
PY  - 2017
DO  - 10.1186/s12986-017-0213-3
SN  - 1743-7075
UR  - http://hdl.handle.net/10668/11561
T2  - Nutrition & metabolism
AB  - Limited prospective studies have examined changes in non-alcoholic fatty-liver disease (NAFLD) related serum-metabolites and none the effects of NAFLD-reversion. We aimed to evaluate whether perturbations in metabolites indicate predisposition to...
LA  - en
PB  - BioMed Central
KW  - Fatty acid metabolism
KW  - Hepatic lipotoxicity
KW  - Metabolomics
KW  - Non-alcoholic fatty liver disease
KW  - Non-alcoholic fatty liver disease
KW  - Sphingomyelins
KW  - Cholesterol esters
KW  - Prospective studies
KW  - Ceramides
KW  - Triglycerides
KW  - Metabolome
KW  - Mass spectrometry
KW  - Chromatography
TI  - Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial.
TY  - research article
VL  - 14
ER  -